ArticleThe international journal of cardiovascular imaging2025
The utility of real-time transthoracic 3-dimensional echocardiography in congenital heart disease in current clinical practice.
Article in The international journal of cardiovascular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Three-dimensional transthoracic echocardiography for the assessment of infantile cor triatriatum sinister.Journal of medical ultrasonics (2001) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To evaluate the utility of three-dimensional transthoracic echocardiography (3D TTE) in the assessment and management of congenital heart disease (CHD). The use of three-dimensional TTE with both pediatric and adult patients has helped to clarify the cardiac anatomy and hemodynamic physiologic lesions in CHD. However, few practical aspects of 3D TTE have undergone systematic review. A retrospective study of CHD patients from January-December 2022 who underwent 3D TTE was conducted to determine the utility of 3D TTE with respect to answering the primary diagnostic question, adding diagnostic information to 2D imaging, concordance with 2D TTE or cardiac CT, and impact on management. During the study period, 76 CHD patients underwent 3D TTE at a median age of 104 months (IQR 29-175.5). The common cardiac segment under investigation was related to the atrioventricular valve. The mean heart rate was 89 ± 20 BPM. The mean volume rate was 17 ± 5. The single beat acquisition was used in all cases. Sedation use was infrequent (22.67%). Three-dimensional TTE answered the primary diagnostic question and added diagnostic information to 2D TTE imaging in all cases (100%). Additionally, 3D TTE impacted the management of the following: provided guided intervention (3/76, 4%), provided information before cardiac surgery (27/76, 36%), and increased understanding of the cardiac anatomy (76/76, 100%). Three-dimensional TTE can be applied in simple to complex CHD cases, across all age groups, from infants to adults. It provides real-time performance, requires no radiation, and infrequent use of sedation. This study showed that 3D TTE was accurate, answered the diagnostic questions in all cases, and frequently added diagnostic information that impacted management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.